These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 10534250)

  • 41. The modulation of somatosensory evoked potentials during the foreperiod of a forewarned reaction time task.
    Böcker KB; Forget R; Brunia CH
    Electroencephalogr Clin Neurophysiol; 1993; 88(2):105-17. PubMed ID: 7681751
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Gating of the early components of the frontal and parietal somatosensory evoked potentials in different sensory-motor interference modalities.
    Cheron G; Borenstein S
    Electroencephalogr Clin Neurophysiol; 1991; 80(6):522-30. PubMed ID: 1720728
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Increased corticomotoneuronal excitability after peripheral nerve stimulation in dopa-nonresponsive hemiparkinsonism.
    Yokota T; Saito Y; Shimizu Y
    J Neurol Sci; 1995 Mar; 129(1):34-9. PubMed ID: 7751842
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Treatment of Parkinson's disease: levodopa as the first choice.
    Katzenschlager R; Lees AJ
    J Neurol; 2002 Sep; 249 Suppl 2():II19-24. PubMed ID: 12375059
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Right or left ear reference changes the voltage of frontal and parietal somatosensory evoked potentials.
    Tomberg C; Desmedt JE; Ozaki I
    Electroencephalogr Clin Neurophysiol; 1991; 80(6):504-12. PubMed ID: 1720726
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [The value of differential recording of subcortical somatosensory evoked potentials (SEP) in neurosurgery].
    Wagner W
    Zentralbl Neurochir; 1996; 57(2):89-96. PubMed ID: 8779274
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Methylphenidate increases the motor effects of L-Dopa in Parkinson's disease: a pilot study.
    Camicioli R; Lea E; Nutt JG; Sexton G; Oken BS
    Clin Neuropharmacol; 2001; 24(4):208-13. PubMed ID: 11479391
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Somatosensory input to non-primary motor areas is enhanced during preparation of cued contraterlateral finger sequence movements.
    Brown MJ; Staines WR
    Behav Brain Res; 2015 Jun; 286():166-74. PubMed ID: 25746454
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Abnormal processing of the nociceptive input in Parkinson's disease: a study with CO2 laser evoked potentials.
    Tinazzi M; Del Vesco C; Defazio G; Fincati E; Smania N; Moretto G; Fiaschi A; Le Pera D; Valeriani M
    Pain; 2008 May; 136(1-2):117-24. PubMed ID: 17765400
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Abnormalities of somatosensory evoked potentials in spasmodic torticollis.
    Mazzini L; Zaccala M; Balzarini C
    Mov Disord; 1994 Jul; 9(4):426-30. PubMed ID: 7969209
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Cervical spine manipulation alters sensorimotor integration: a somatosensory evoked potential study.
    Haavik-Taylor H; Murphy B
    Clin Neurophysiol; 2007 Feb; 118(2):391-402. PubMed ID: 17137836
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effect of deep brain stimulation and L-Dopa on electrocortical rhythms related to movement in Parkinson's disease.
    Devos D; Defebvre L
    Prog Brain Res; 2006; 159():331-49. PubMed ID: 17071241
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Focal capsular vascular lesions can selectively deafferent the prerolandic or the parietal cortex: somatosensory evoked potentials evidence.
    Mauguière F; Desmedt JE
    Ann Neurol; 1991 Jul; 30(1):71-5. PubMed ID: 1929229
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [The repeat reliability of somatosensory evoked potentials].
    Strenge H
    EEG EMG Z Elektroenzephalogr Elektromyogr Verwandte Geb; 1989 Sep; 20(3):147-52. PubMed ID: 2507277
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Prognostic value of somatosensory-evoked potentials in the surgical management of cervical spondylotic myelopathy.
    Hu Y; Ding Y; Ruan D; Wong YW; Cheung KM; Luk KD
    Spine (Phila Pa 1976); 2008 May; 33(10):E305-10. PubMed ID: 18449030
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Motor and somatosensory evoked potentials in Autosomal Dominant Hereditary Spastic Paraparesis (ADHSP) linked to chromosome 2p, SPG4.
    Sartucci F; Tovani S; Murri L; Sagliocco L
    Brain Res Bull; 2007 Sep; 74(4):243-9. PubMed ID: 17720546
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Sensory nerve conduction velocity determined by somatosensory evoked potentials in patients with hereditary motor and sensory neuropathy type I].
    Takada H; Ozaki I; Kurihara A; Baba M; Matsunaga M
    Rinsho Shinkeigaku; 1995 Jan; 35(1):76-9. PubMed ID: 7781221
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Electroencephalographic lateralization, clinical correlates and pharmacological response in untreated Parkinson's disease.
    Mostile G; Nicoletti A; Dibilio V; Luca A; Pappalardo I; Giuliano L; Cicero CE; Sciacca G; Raciti L; Contrafatto D; Bruno E; Sofia V; Zappia M
    Parkinsonism Relat Disord; 2015 Aug; 21(8):948-53. PubMed ID: 26096796
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effect of supplemental carbidopa on bioavailability of L-dopa.
    Cedarbaum JM; Kutt H; Dhar AK; Watkins S; McDowell FH
    Clin Neuropharmacol; 1986; 9(2):153-9. PubMed ID: 3085927
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [The pain components of somatosensory evoked potentials induced by median nerve stimulation P200-N300].
    Pan W; Xia Y; Zhang R; Yi P
    Zhen Ci Yan Jiu; 1993; 18(1):21-3. PubMed ID: 8082275
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.